Literature DB >> 17051755

Coronary revascularization in a patient with immune thrombocytopenic purpura.

Man-Cai Fong1, Kuan-Chun Chen, Hsin-Bang Leu, Lung-Ching Chen.   

Abstract

Immune thrombocytopenic purpura (ITP) is a bleeding disorder characterized by premature platelet destruction mediated by autoantibodies. We report a 71-year-old ITP patient with concomitant acute coronary syndrome. Cardiac catheterization was performed through the right radial artery and premedicated with immunoglobulin. Left anterior descending artery was stented, followed by clopidogrel treatment for 7 weeks without major bleeding complication. The patient has been observed for 2 years without clinical restenosis. We suggest that stent implantation is a safe treatment in this special condition. Treatment should be individualized, but it is still a challenge to balance bleeding and thrombosis complication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17051755     DOI: 10.1016/S1726-4901(09)70287-4

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  10 in total

Review 1.  Retention of atherogenic lipoproteins in atherogenesis.

Authors:  M Gustafsson; C Flood; P Jirholt; J Borén
Journal:  Cell Mol Life Sci       Date:  2004-01       Impact factor: 9.261

2.  Acute ST Elevation Myocardial Infarction in Patients With Immune Thrombocytopenia Purpura: A Case Report.

Authors:  Sandeep K Dhillon; Edwin Lee; John Fox; Maurice Rachko
Journal:  Cardiol Res       Date:  2011-01-20

Review 3.  Primary PCI for acute myocardial infarction in a patient with idiopathic thrombocytopenic purpura. A case report and review of the literature.

Authors:  Aleksandar N Neskovic; Ivan Stankovic; Predrag Milicevic; Aleksandar Aleksic; Alja Vlahovic-Stipac; Branko Calija; Biljana Putnikovic
Journal:  Herz       Date:  2010-02-09       Impact factor: 1.443

4.  Primary percutaneous coronary intervention for acute myocardial infarction in a young female with idiopathic thrombocytopenic purpura: a case report and review.

Authors:  Ahmet Yildiz; Ugur Coskun; Ozlem Esen Batukan; Kudret Keskin
Journal:  Case Rep Med       Date:  2010-03-24

5.  Recurrent ischemic stroke in a patient with idiopathic thrombocytopenic purpura.

Authors:  Hak Young Rhee; Hye-Yeon Choi; Sang-Beom Kim; Won-Chul Shin
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

6.  Revascularization for patients with idiopathic thrombocytopenic purpura and coronary artery disease.

Authors:  Chan-Hee Lee; Ung Kim
Journal:  Korean Circ J       Date:  2014-07-25       Impact factor: 3.243

Review 7.  Two cases and review of the literature: primary percutaneous angiography and antiplatelet management in patients with immune thrombocytopenic purpura.

Authors:  Estelle Torbey; Harout Yacoub; Donald McCord; James Lafferty
Journal:  ISRN Hematol       Date:  2013-12-29

8.  Coronary intervention for acute coronary syndrome in a 51-year-old man with immune thrombocytopenic purpura: a case report.

Authors:  Bora Demircelik; Meltem Altinsoy; Fadime Bozduman; Mahmut Gunes; Muzaffer Cakmak; Beyhan Eryonucu
Journal:  J Med Case Rep       Date:  2014-06-20

Review 9.  Recurrent acute coronary syndrome and restenosis after percutaneous coronary intervention in a patient with idiopathic thrombocytopenic purpura: a case report and literature review.

Authors:  Ge Li-Sha; Chen Peng; Li Yue-Chun
Journal:  BMC Cardiovasc Disord       Date:  2015-09-18       Impact factor: 2.298

10.  Short-term follow-up results of drug-eluting stenting in premature coronary artery disease patients with multiple atherosclerotic risk factors.

Authors:  Ming-Hsiung Wang; Wen-Lieng Lee; Kuo-Yang Wang; Yu-Cheng Hsieh; Tsun-Jui Liu; I-Hsiang Lin; Wei-Wen Lin; Chih-Tai Ting; Kae-Woei Liang
Journal:  J Chin Med Assoc       Date:  2008-07       Impact factor: 2.743

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.